Drug intelligence / Profile preview

2-(2,6-difluorophenoxy)-N-(2-fluorophenyl)-9-isopropyl-9H-purin-8-amine

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

This compound is a synthetic purine derivative classified as a small molecule. It is known by the code names LIE and PD004749. Structurally, it features a purine core substituted with difluorophenoxy and fluorophenyl groups as well as an isopropyl moiety. The compound has been studied primarily as an experimental inhibitor of mitogen‑activated protein kinase 14 (MAPK14), also known as p38 alpha MAP kinase. This target plays a key role in inflammatory signaling pathways and cellular responses to stress. The molecule has been co-crystallized with mouse MAPK14 in structural biology studies but does not have any approved therapeutic indications or evidence of clinical development beyond preclinical research[7][4][9]. Its main relevance lies in biochemical research on kinase inhibition.

Other names
2-(2,6-difluorophenoxy)-N-(2-fluorophenyl)-9-isopropylpurin-8-amine9H-purin-8-amine, 2-(2,6-difluorophenoxy)-N-(2-fluorophenyl)-9-(1-methylethyl)-904914-13-2
02

Targets

MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on 2-(2,6-difluorophenoxy)-N-(2-fluorophenyl)-9-isopropyl-9H-purin-8-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(2,6-difluorophenoxy)-N-(2-fluorophenyl)-9-isopropyl-9H-purin-8-amine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call